Navigation Links
MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited
Date:6/24/2008

MOUNTAIN VIEW, Calif., June 24 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that Telesso Technologies Limited, formerly Eiffel Technologies Limited ("Eiffel"), has agreed to transfer and assign to MAP Pharmaceuticals previously licensed intellectual property and know-how, as well as capital equipment, owned by Eiffel related to its supercritical fluid technology ("SCF").

MAP Pharmaceuticals will make payments to Eiffel upon the successful transfer of the intellectual property and related capital equipment. Eiffel will receive milestone payments upon achievement of certain late stage clinical and regulatory milestones for the first product developed by MAP Pharmaceuticals using the Eiffel technology. The new agreement supersedes the research and development agreement entered into by the companies in 2005 and eliminates all royalty and milestone commitments under the previous agreement.

Since 2005, MAP Pharmaceuticals and Eiffel have collaborated on the development of methods for manufacturing drug particles either alone, or as a combination of two drugs in a single particle, using Eiffel's SCF technology. The technology has been shown in clinical studies to be applicable to inhaled formulations of biologics and combination drug products. MAP Pharmaceuticals believes the technology may also apply to the combination of three different drugs into a single particle for inhalation or for use in other dosage forms.

"This acquisition allows MAP Pharmaceuticals to assume direct control of processing and manufacturing of drug formulations relating to the SCF technology, while also allowing full control of intellectual property," said Timothy S. Nelson, President and Chief Executive Officer
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Bradley, Illinois (PRWEB) May 20, 2013 ... assisted living community in Lake County, Illinois, is hosting ... 24. , The community, which is located at 3775 ... all incomes, including those on Medicaid, who need some ... our delicious breakfast buffet and games of bingo," says ...
(Date:5/20/2013)... (PRWEB) May 21, 2013 The ... product type into two categories - semi-automated and ... is classified into five categories, namely, hospitals, pre-hospital, ... is forecast till 2017. Automated external defibrillators play ... sudden cardiac arrest victims. Considering the life-saving potential ...
(Date:5/20/2013)... Minneapolis, MN (PRWEB) May 20, 2013 When ... right bed is only part of the process. Much of ... over the internet involves not knowing what to expect. ... expert advice consumers can use to ensure their purchase proves ... When You Buy a Mattress Online ”, readers find helpful ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Recent ... importance of using green and sustainable inputs in ... has implemented regulations to promote the use of ... Packaging and Labelling Services industry . “Tax subsidies ... trend,” says IBISWorld industry analyst Deonta Smith. “For ...
(Date:5/20/2013)... Fastcare Miami Beach clinic advises patients to treat ... as if not treated, it may involve the ureter and ... urinary tract infection in itself is not life threatening, if ... pyelonephritis. Women seem to have many more urinary tract infections ... as women after the age of fifty. , As ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Fastcare Advises on How to Prevent a UTI 2
... for Home Oxygen Therapy to Less Than Half of 1997 ... prepare to celebrate the New Year, the home oxygen community ... Medicare policy changes that will present many challenges to beneficiaries ... in the form of a 36-month cap on payments for ...
... WASHINGTON, Dec. 31 Each Sunday throughout January, ... that tells the compelling and inspirational stories of ... six-time Grammy Award winner Naomi Judd. Sharing Miracles ... across the United States. Judd, one-half of the ...
... Ltd. (NYSE Alternext,US: SVA), a leading provider of vaccines ... the Company,s inactivated hepatitis A vaccine,Healive(R), following a report ... District,in the City of Beijing on November 27, 2008. ... autopsy results, the death was caused by,myocarditis, an inflammation ...
... Calif., Dec. 31 Watson Pharmaceuticals, Inc. (NYSE: ... and specialty branded pharmaceuticals, today announced that its ... the United States Food and Drug Administration to ... mint flavor, in the 2 mg and 4 ...
... to Dock, a U.S. based Non-Governmental Organization (NGO), sent over $3,000,000 ... ... (Vocus) December 31, 2008 -- In a continent often ... attention paid to the many uplifting success stories. Among ...
... biopsy is still considered the gold standard for grading, ... it remains a primary source for acquiring new knowledge ... the fibrosis and inflammatory tissue detectable in liver biopsy ... the closest-to-real effects of new antiviral molecules on the ...
Cached Medicine News:Health News:Massive Cuts to Medicare Home Oxygen Therapy Benefit Taking Effect January 1 Creating Acute Anxiety Among Beneficiary and Provider Communities 2Health News:Massive Cuts to Medicare Home Oxygen Therapy Benefit Taking Effect January 1 Creating Acute Anxiety Among Beneficiary and Provider Communities 3Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 2Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 3Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 4Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 5Health News:'Sharing Miracles' Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd 6Health News:Sinovac Announces that Government Investigation Rules Out Healive's Role in Child's Death 2Health News:Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum 2Health News:Good News in Africa: Beyond the headlines 2Health News:A rigorous method for liver biopsy 2
(Date:5/20/2013)... , May 21, 2013   ... where world,s health ministers gather to address the large ... Mental and neurological disorders (MNDs) affect 700 million people ... disease (NCD) burden ,Do You Mind?, helps ... role each can play to collectively address MNDs , ...
(Date:5/20/2013)... 20, 2013  Volcano Corporation (NASDAQ: VOLC ... therapy tools designed to enhance the diagnosis and treatment ... will highlight its efforts to expand research and innovation ... (FFR) and iFR ® (Instant Wave-Free Ratio™) 1 ... events at EuroPCR 2013 in Paris ...
(Date:5/20/2013)... , May 20, 2013  B. Braun Medical ... and environmental safety with products, services and education ... feature its innovative Outlook® 400ES and Space Infusion ... capabilities at the American Association of Critical-Care Nurses ... Boston Convention Center. ...
Breaking Medicine Technology:Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 3Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 4B. Braun Committed To Improving Patient Safety 2
... Company (NASDAQ: STAA ) today announced that it will release ... Wednesday, May 2, 2012 after the market close. ... on Wednesday, May 2, 2012 at 4:30 p.m. Eastern / ... Company,s first quarter 2012 results and recent corporate developments. The dial-in number ...
... first center dedicated to treating spine patients with the ... today, April 25, in Chicago. The Midwest Orthopaedics at ... in MOR,s new, state-of-the-art building, 1611 W. Harrison ... Phillips and Kern Singh, board-certified orthopedic spine surgeons ...
Cached Medicine Technology:STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast 2Midwest Orthopaedics at Rush Minimally Invasive Spine Institute Opens Today 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: